Mary Armanios, M.D. is the Clinical Director of the Telomere Center at Johns Hopkins, Associate Director of Cancer Research Career Enhancement, Sidney Kimmel Comprehensive Cancer Center, Professor of Oncology, Genetic Medicine, Molecular Biology and Genetics, and Pathology as well as an active researcher.
Dr. Armanios focuses her research on disorders caused by telomere dysfunction and specific to this webinar, the implications for patients with MDS and AML.
Short telomere syndrome is a genetic mutation that has significant implications for MDS and AML patients. This interaction webinar will provide an overview of the subject and will address the specific impact for bone marrow failure disease patients. Participants will be able to ask questions during the live webinar via the text chat window.
Thank you for registering for "Short Telomere Syndrome: Implications for MDS and AML Patients", November 19, 2020 at 2:30pm EDT.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone. If you do not receive the link,
please check your Spam/Junk folders.
If you have not received a registration confirmation, please email firstname.lastname@example.org
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.